APA

Kidd L. R., Jones D. Z., Rogers E. N., Kidd N. C., Beache S., Rudd J. E., Ragin C., Jackson M., McFarlane-Anderson N., Tulloch-Reid M., Morrison S., Brock G. N., Barve S. S. & Kimbro K. S. (20121224). Chemokine Ligand 5 (CCL5) and chemokine receptor (CCR5) genetic variants and prostate cancer risk among men of African Descent: a case-control study. : Hereditary cancer in clinical practice.

Chicago

Kidd Lacreis R, Jones Dominique Z, Rogers Erica N, Kidd Nayla C, Beache Sydney, Rudd James E, Ragin Camille, Jackson Maria, McFarlane-Anderson Norma, Tulloch-Reid Marshall, Morrison Seian, Brock Guy N, Barve Shirish S and Kimbro Kevin S. 20121224. Chemokine Ligand 5 (CCL5) and chemokine receptor (CCR5) genetic variants and prostate cancer risk among men of African Descent: a case-control study. : Hereditary cancer in clinical practice.

Harvard

Kidd L. R., Jones D. Z., Rogers E. N., Kidd N. C., Beache S., Rudd J. E., Ragin C., Jackson M., McFarlane-Anderson N., Tulloch-Reid M., Morrison S., Brock G. N., Barve S. S. and Kimbro K. S. (20121224). Chemokine Ligand 5 (CCL5) and chemokine receptor (CCR5) genetic variants and prostate cancer risk among men of African Descent: a case-control study. : Hereditary cancer in clinical practice.

MLA

Kidd Lacreis R, Jones Dominique Z, Rogers Erica N, Kidd Nayla C, Beache Sydney, Rudd James E, Ragin Camille, Jackson Maria, McFarlane-Anderson Norma, Tulloch-Reid Marshall, Morrison Seian, Brock Guy N, Barve Shirish S and Kimbro Kevin S. Chemokine Ligand 5 (CCL5) and chemokine receptor (CCR5) genetic variants and prostate cancer risk among men of African Descent: a case-control study. : Hereditary cancer in clinical practice. 20121224.